Emily Carroll

404 total citations
14 papers, 218 citations indexed

About

Emily Carroll is a scholar working on Oncology, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emily Carroll has authored 14 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Neurology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emily Carroll's work include Cancer Immunotherapy and Biomarkers (6 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Emily Carroll is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Amyotrophic Lateral Sclerosis Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (3 papers). Emily Carroll collaborates with scholars based in United States, United Kingdom and Germany. Emily Carroll's co-authors include Thomas H. Gillingwater, Emily J. Gallagher, Matthew D. Galsky, Kevin Talbot, Amanda Leiter, Dorothée Lulé, Chris-Anne McKenzie, Elaine Cleary, Sharon Abrahams and Albert C. Ludolph and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Acta Neuropathologica.

In The Last Decade

Emily Carroll

13 papers receiving 216 citations

Peers

Emily Carroll

NEURO

CMN

GENET

PHYSI

Amaly Nokkari Lebanon

Kon-Ping Lin Taiwan

Elisabeth Rossaert Belgium

Bailey Baumann United States

W Ambrose McGee United States

Donatella Bardelli Italy

Avi Fellner Israel

Martina de Majo United States

Joke Dhondt Belgium

Matthew Nolan United Kingdom

Amaly Nokkari Lebanon

Emily Carroll

61 ×0.7

NEURO

141 ×1.7

42 ×0.9

CMN

66 ×1.5

GENET

21 ×0.5

PHYSI

Citations per year, relative to Emily Carroll Emily Carroll (= 1×) peers Amaly Nokkari

Countries citing papers authored by Emily Carroll

Since Specialization

Citations

This map shows the geographic impact of Emily Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Carroll more than expected).

Fields of papers citing papers by Emily Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Carroll. The network helps show where Emily Carroll may publish in the future.

Co-authorship network of co-authors of Emily Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Carroll. A scholar is included among the top collaborators of Emily Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Carroll. Emily Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Carroll, Emily, et al.. (2025). Recent developments in gene therapy for Parkinson’s disease. Molecular Therapy. 33(5). 2052–2064. 3 indexed citations

Carroll, Emily, Jakub Scaber, K. Huber, et al.. (2025). Drug repurposing in amyotrophic lateral sclerosis (ALS). Expert Opinion on Drug Discovery. 20(4). 447–464. 2 indexed citations

Dafinca, Ruxandra, Emily Carroll, Björn F. Vahsen, et al.. (2024). Dynactin-1 mediates rescue of impaired axonal transport due to reduced mitochondrial bioenergetics in amyotrophic lateral sclerosis motor neurons. Brain Communications. 6(5). fcae350–fcae350. 2 indexed citations

Vahsen, Björn F., Lucy Farrimond, Emily Carroll, et al.. (2023). C9orf72-ALS human iPSC microglia are pro-inflammatory and toxic to co-cultured motor neurons via MMP9. Nature Communications. 14(1). 5898–5898. 34 indexed citations

Chaytow, Helena, Emily Carroll, David F. Gordon, et al.. (2022). Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis. EBioMedicine. 83. 104202–104202. 34 indexed citations

Leiter, Amanda, et al.. (2021). Metabolic disease and adverse events from immune checkpoint inhibitors. European Journal of Endocrinology. 184(6). 857–865. 19 indexed citations

Hasenpusch‐Theil, Kerstin, Christine Laclef, Katherine Howe, et al.. (2020). A transient role of the ciliary gene Inpp5e in controlling direct versus indirect neurogenesis in cortical development. eLife. 9. 15 indexed citations

Leiter, Amanda, Emily Carroll, Robert Yanagisawa, et al.. (2020). SAT-411 Vitamin D Levels and Risk of Thyroid Immune Related Adverse Events in Patients on Immune Checkpoint Inhibitors. Journal of the Endocrine Society. 4(Supplement_1). 1 indexed citations

Patel, Vaibhav G., Qian Qin, Bo Wang, et al.. (2020). Characterizing patterns of disease progression in patients with genitourinary cancers treated with immune checkpoint inhibitors.. Journal of Clinical Oncology. 38(6_suppl). 482–482.

10.

Qin, Qian, Vaibhav G. Patel, Bo Wang, et al.. (2020). Type, timing, and risk factors associated with immune-related adverse event development in patients with advanced genitourinary cancers treated with immune checkpoint inhibitor.. Journal of Clinical Oncology. 38(6_suppl). 480–480. 1 indexed citations

11.

Sindhu, Kunal K., Amanda Leiter, Erin Moshier, et al.. (2020). Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade. Cancer Treatment and Research Communications. 25. 100216–100216. 10 indexed citations

12.

Leiter, Amanda, et al.. (2020). Characterization of hyperglycemia in patients receiving immune checkpoint inhibitors: Beyond autoimmune insulin-dependent diabetes. Diabetes Research and Clinical Practice. 172. 108633–108633. 11 indexed citations

13.

Leiter, Amanda, et al.. (2019). SAT-094 Overweight and Obesity Associated with Immune-Related Adverse Events in Patients on Immune Checkpoint Inhibitor Therapy. Journal of the Endocrine Society. 3(Supplement_1). 1 indexed citations

14.

Henstridge, Christopher M., Emily Carroll, Makis Tzioras, et al.. (2017). Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis. Acta Neuropathologica. 135(2). 213–226. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact